TickerFactsScreenerDevelopers

Propanc Biopharma, Inc. (PPCB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$1.40M2012: -$170.3K2014: $226.4K2017: -$2.05M2018: -$2.18M2019: -$2.06M2020: -$1.85M2021: -$1.15M2022: -$1.44M2023: -$1.11M2024: -$935.1K2025: -$405.2K-$405.2K
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$405.2K+56.7%
2024-$935.1K+15.4%
2023-$1.11M+23.0%
2022-$1.44M-25.4%
2021-$1.15M+38.1%
2020-$1.85M+10.2%
2019-$2.06M+5.4%
2018-$2.18M-6.2%
2017-$2.05M—
2014$226.4K—
2012-$170.3K+87.8%
2011-$1.40M—